Results 21 to 30 of about 651,421 (240)

Chronic Liver Disease among Patients Admitted in the Department of Internal Medicine of a Tertiary Care Centre: A Descriptive Cross-sectional Study

Journal of Nepal Medical Association, 2023
Introduction: Chronic liver disease with cirrhosis is a significant cause of morbidity and mortality not only in developed but also in developing countries.
Sujan Chandra Poudel, Abishkar Acharya, Sujata Maharjan, Saroj GC, Reshika Shrestha, Suraksha Thapa, Shekhar Poudel   +6 more
doaj   +1 more source

Immunoglobulin A and liver diseases. [PDF]

, 2017
Immunoglobulin A (IgA) is a major immunoglobulin isotype in the gut and plays a role in maintenance of gut homeostasis. Secretory IgA (SIgA) has multiple functions in the gut, such as to regulate microbiota composition, to protect intestinal epithelium ...
Inamine, Tatsuo, Schnabl, Bernd
core   +2 more sources

Role of Oxidative Stress in the Pathogenesis of Non-Alcoholic Fatty Liver Disease: Implications for Prevention and Therapy

Antioxidants, 2021
Oxidative stress (OxS) is considered a major factor in the pathophysiology of inflammatory chronic liver diseases, including non-alcoholic liver disease (NAFLD).
J. C. Arroyave-Ospina, Zongmei Wu, Yana Geng, H. Moshage   +3 more
semanticscholar   +1 more source

Comparative Study on Serum Enzyme Levels in Cirrhosis of Liver and Alcoholic Liver Disease [PDF]

, 2022
Patients with chronic liver diseases are asymptomatic or have only vague non-specific symptoms. Effective medical treatments for chronic liver disease (before cirrhosis is established) are becoming increasingly available and since abnormal LFTs may be ...
Ershad, R, Mahaboob, Salma, Obulesu , G, Rjeshwari, P   +3 more
core   +1 more source

Diagnosis and Treatment of Alcohol‐Associated Liver Diseases: 2019 Practice Guidance From the American Association for the Study of Liver Diseases

Hepatology, 2020
Alcoholic liver disease (ALD) represents a spectrum of liver injury resulting from alcohol use, ranging from hepatic steatosis to more advanced forms including alcoholic hepatitis (AH), alcoholic cirrhosis (AC), and acute alcoholic hepatitis presenting ...
D. Crabb, G. Im, G. Szabo, Jessica L. Mellinger, M. Lucey   +4 more
semanticscholar   +1 more source

Changes in Glutathione Content in Liver Diseases: An Update

Antioxidants, 2021
Glutathione (GSH), a tripeptide particularly concentrated in the liver, is the most important thiol reducing agent involved in the modulation of redox processes.
M. Vairetti, L. G. Di Pasqua, M. Cagna, P. Richelmi, A. Ferrigno, C. Berardo   +5 more
semanticscholar   +1 more source

Oxidative stress: new insights on the association of nonalcoholic fatty liver disease and atherosclerosis [PDF]

, 2015
Non-alcoholic fatty liver disease (NAFLD) represents the most common and emerging chronic liver disease worldwide. It includes a wide spectrum of liver diseases ranging from simple fatty liver to non-alcoholic steatohepatitis (NASH), which may progress ...
Albanese, Fabiana, Angelico, Francesco, Baratta, Francesco, DEL BEN, Maria, Pastori, Daniele, Perri, Ludovica, Polimeni, Licia, Violi, Francesco   +7 more
core   +1 more source

The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology.

Gastroenterology, 2012
The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology NAGA CHALASANI, MD, FACG,
N. Chalasani, Z. Younossi, J. Lavine, A. Diehl, E. Brunt, K. Cusi, M. Charlton, A. Sanyal   +7 more
semanticscholar   +1 more source

Bile Acid Receptor Therapeutics Effects on Chronic Liver Diseases [PDF]

, 2020
In the past ten years, our understanding of the importance of bile acids has expanded from fat absorption and glucose/lipid/energy homeostasis into potential therapeutic targets for amelioration of chronic cholestatic liver diseases.
Alpini, Gianfranco, Francis, Heather, Kennedy, Lindsey, Kundu, Debjyoti, Meadows, Vik   +4 more
core   +1 more source

Research progress of functional active peptides in the prevention and treatment of alcoholic liver injury [PDF]

Zhongguo niangzao
China is a large country of liver diseases, the popularization of anti-hepatitis virus drugs is an effective means of infectious disease prevention and treatment in China, which makes the incidence of infectious hepatitis continue to decline.
HE Linfeng, LUO Tao, WANG Cong, TANG Wendi
doaj   +1 more source